AINewsnow

Eli Lilly Licenses ADDF's SpeechDx Dataset for Alzheimer's Research

The Alzheimer's Drug Discovery Foundation (ADDF) announced on October 28, 2026 that Eli Lilly and Company has licensed SpeechDx, a longitudinal speech-and-biomarker dataset built by the foundation's Diagnostics Accelerator, and will use the resource to study whether speech can serve as a tool for A…

Read the full story at Unite.AI ↗

Timeline · 1 report

  1. 2026-10-28 16:06 · Unite.AI
    Eli Lilly Licenses ADDF's SpeechDx Dataset for Alzheimer's Research

More stories

  1. Gemini 4 Carbon: our next frontier model — Google Gemini Blog
  2. NVIDIA Nemotron 3.5 Transcribe and Granary v2: Intelligent Multilingual Transcription You Can Prompt and Adapt — Hugging Face Blog
  3. PyTorch 2.15 Release Blog — PyTorch Blog
  4. Startups, Did You Know That Agentforce Coworker Can Do This? — Salesforce AI Blog
  5. Building an Agentic AI Platform on Amazon Bedrock AgentCore — AWS Machine Learning Blog
  6. As AI agents reshape the web, Google opens Gemini and Search to more apps — TechCrunch AI
  7. Distributed training with Ray Train DLCs and EFA on EKS — AWS Machine Learning Blog
  8. Accelerating software delivery with agentic QA automation using Amazon Nova Act – Part 3 — AWS Machine Learning Blog

Get the daily brief of stories like this at 6:30 every morning →